Polynucleotides Injectable Market 2030: The Future of Personalized Medicine

Polynucleotides Injectable Market Size & Trends

The global polynucleotides injectable market size was estimated at USD 127.6 million in 2024 and is projected to grow at a CAGR of 15.1% from 2025 to 2030. Technological advancements in biotechnology primarily drive market growth, as do the increasing demand for skin rejuvenation, personalized medicine, and investments in research and development (R&D). According to an article published by PMTA Journal in March 2024, polynucleotide injections gained prominence in aesthetic medicine due to their beneficial effects on skin, hair, and other tissues, as explored in this comprehensive review.

The growing demand for advanced skin rejuvenation treatments is a primary driver of the polynucleotides injectable industry. As individuals seek more effective solutions to address signs of aging, such as fine lines, wrinkles, and skin laxity, the interest in novel injectable treatments such as polynucleotides has surged. For instance, a recent study published in the journal Dermatologic Therapy found that polynucleotide injections improved skin tone, fine lines, skin elasticity, and hydration in patients in their 30s and 40s.

Get a preview of the latest developments in the Polynucleotides Injectable Market; Download your FREE sample PDF copy today and explore key data and trends

Polynucleotides Injectable Market Size, By Application, 2020 - 2030 (USD Million)

The increasing focus on personalized medicine also contributed to the growth of the market. As healthcare providers and patients alike seek customized approaches to skin rejuvenation, polynucleotides' ability to stimulate the body's natural collagen production and cellular regeneration has made them a popular choice. This trend is particularly evident in the rising demand for personalized aesthetic treatments, which is expected to continue expanding the market.

Finally, integrating innovative technologies, such as digital imaging and automated injection systems, has further propelled the polynucleotides injectable industry. These advancements improved polynucleotide injections' precision, consistency, and safety, making them more appealing to healthcare providers and patients. As the aesthetic industry continues to evolve, incorporating cutting-edge technologies is expected to remain a vital driver of the polynucleotide injectable industry. For instance, in 2022, Pulse Light Clinic in London is introducing PhilArt by Croma, an innovative polynucleotide injection treatment recognized for significantly enhancing skin hydration, boosting elasticity, and stimulating natural collagen production - a pioneering advancement in skin rejuvenation.

Polynucleotides Injectable Market Report Highlights

  • The eye segment held the largest revenue share of 63.9% in 2024, driven by the growing demand for non-invasive solutions to address various eye-related concerns.
  • The forehead segment is anticipated to register the fastest CAGR over the forecast period.
  • The MedSpas segment held the largest revenue share of 45.5% in 2024, driven by consumers' growing demand for non-invasive aesthetic treatments.
  • The Aesthetic & Cosmetic Centers segment is expected to grow at a significant rate over the forecast period.
  • The polynucleotides injectable market in North America has been experiencing significant growth in recent years due to increasing demand for advanced therapies and the presence of essential players in the region.
  • The Asia Pacific polynucleotide injectable market held the largest revenue share of 47.7% in 2024 as the region is witnessing several key trends, including the emergence of domestic players offering low-cost products to expand market access and affordability.

Polynucleotides Injectable Market Segmentation

Grand View Research has segmented the global polynucleotides injectable market report based on application, end-use, and region:

Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Eyes
  • Lips
  • Forehead
  • Jawline & Cheekbones
  • Others

End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • MedSpas
  • Aesthetic & Cosmetic Centers
  • Hospitals

Regional Outlook (Revenue, USD Million, 2018 - 2030) 

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Curious about the Polynucleotides Injectable Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends.

Comments

Post a Comment

Popular posts from this blog

India Electric Vehicle Market Competitive Landscape Report to 2028

Image
India Electric Vehicle Industry Overview The India electric vehicle market size was valued at USD 220.1 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 94.4% from 2021 to 2030. The attractive incentives being offered by the Indian government on the production and purchase of electric vehicles to encourage the adoption of electric vehicles are anticipated to drive the growth of the market over the forecast period. The outbreak of the COVID-19 pandemic triggered a significant decline in the overall sales of passenger and commercial vehicles in 2020. However, the sales of electric vehicles in India remained unaffected. The post-lockdown sale of pure and hybrid electric vehicles is a prominent driving factor for the electric vehicle market in India. The stringent GreenHouse gas (GHG) emission norms drafted by the government, such as the Bharat Stage (BS) VI emission standards introduced by India’s Ministry of Road Transport and Highways (MoRTH), ...
Read more

Digital Pathology Market 2030: Key Trends Shaping the Future of Healthcare

Image
Digital Pathology Market Growth & Trends The global  digital pathology market  size is expected to reach USD 1.73 billion by 2030, registering a CAGR of 8.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness exponential growth owing to rising prevalence of chronic diseases aided by increasing demand for accurate diagnostics. Chronic diseases affect nearly one in every three adults. Whereas, according to the CDC, in the U.S., approximately, 51.8% of adults have at least one chronic disease. Digital pathology, including molecular tissue profiling, biobanking, tissue microarray analysis, and molecular biology, plays an important role in the drug development pipeline and companion diagnostics. Growing demand for high-quality tissue samples in tissue-based biomarker research is expected to drive technology adoption over the forecast period. Increasing adoption of telepathology with the launch of newer...
Read more

Greenhouse Market 2030: The Impact of Urbanization on Agricultural Practices

Image
Greenhouse Market Growth & Trends The global  greenhouse market  size is anticipated to reach USD 53.51 billion by 2030, registering a CAGR of 9.9% over the forecast period, according to a new report by Grand View Research, Inc. The rise in food consumption is related to the development of contemporary agricultural practices such as greenhouse farming. According to the Food and Agriculture Organization (FAO) of the United Nations, 70% of food production must increase by 2050 to meet world food demand. Consequently, rising population and urbanization, along with a lack of arable land, are driving the use of alternative agricultural practices such as greenhouse farming. Greenhouse farming has enormous potential to assist satisfy the growing population demands witnessed in several nations such as China and India. Indoor farming techniques including vertical farming and greenhouse farming have several advantages over traditional agricultural methods, including...
Read more